Dr. Vishy Chebrol

Director

He is the Founder of Parami Partners, an investment platform dedicated to buy outs and investments in pharmaceutical and medical devices sectors. Prior to that, he was the Co founder and Chief Investment Officer of InvAscent , a mid market private equity firm providing growth capital catering to companies in healthcare sector. Prior to this he worked at Mckinsey and Silvercreek Capital. He has a PhD from Case Western Reserve University and MBA from Indian Institute of Management, Lucknow.

C G K Murthy

Director

Dr Gopalakrishna Murty Chivukula obtained Post Graduate Degree in Pharmaceutical Sciences in 1951 from Andhra University, Vishakhapatnam. Having worked for more than 37 years, retired as Director (1982-1989), Drugs Control Administration, Govt of Andhra Pradesh. He had the distinction of being the first technically qualified officer appointed for the post. Dr Murty was awarded WHO Fellowship in 1969, to study the Drugs Control Administration and Pharma Industry in USA, UK, West Germany, Switzerland, Italy, and Russia.

Dr. Gopalakrishna Murty was a member of Executive Council member of Pharmacy Council of India and President of the Andhra Pradesh Pharmacy Council, Member in the statutory committees like Drugs Consultative Committee and Drugs Technical Advisory Board under Drugs and Cosmetics Act, and held many other honorary positions in the Indian pharmaceutical association at both state and national level.

C S N Murthy

Director

CSN Murthy (CSN) is a Chemical Engineer from IIT, Madras (1984-88), and an MBA from IIM, Bangalore (1988-90).

He started his career at TDICI (now ICICI Ventures), India’s first Venture Capital company. Thereafter, he set up a specialized manufacturing subsidiary for ITW India, part of the US-headquartered industrial consumables company

After a stint as an investment banker, he subsequently worked as the COO for Gland Pharma Limited, before joining Dr. Reddy’s Laboratories Ltd in Corporate Business Development in 2003. 

For over 13 years, he had been the CEO of Aurigene (a wholly owned independent subsidiary of Dr. Reddy’s Laboratories Limited), a successful drug discovery and clinical stage biotech, focused on oncology and auto-immune disorders. Aurigene is the largest drug discovery operation in India, having over 500 scientists; Aurigene has about 15 clinical stage programs in the hands of its partners, and 6 IND/ Ph 1/ Ph 2 programs of its own in oncology and auto-immune disorders.

CSN is also on the Board of a BSE-listed company (Balaji Amines Limited), a successful and leading producer of methyl/ ethyl amines and their derivatves.

CSN is also on the Board of BSE/NSE listed entity Gland Pharma Limited, specializing in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops.